Skip to main content
Top
Published in: Tobacco Induced Diseases 1/2016

Open Access 01-12-2016 | Research

Non-responders in a quitline evaluation are more likely to be smokers – a drop-out and long-term follow-up study of the Swedish National Tobacco Quitline

Authors: Eva Nohlert, John Öhrvik, Ásgeir R. Helgason

Published in: Tobacco Induced Diseases | Issue 1/2016

Login to get access

Abstract

Background

A previous randomized controlled trial (RCT) of the Swedish National Tobacco Quitline detected no significant differences in smoking cessation outcomes between proactive and reactive services at 12-month follow-up. However, the response rate was only 59 % and non-responders were over-represented in the proactive service. We performed a drop-out analysis to assess the smoking status of initial responders and non-responders.

Methods

At 29–48 months after the first call, a postal questionnaire with six questions was sent to 150 random clients from the RCT database, with equal numbers from the proactive and reactive services as well as responders and non-responders at 12-month follow-up. Clients who did not return the questionnaire were contacted by telephone. The outcome measures were point prevalence (PP) and 6-month continuous abstinence (CA), and their associations with response status at 12 months were assessed by logistic regression.

Results

The response rate was 74 % (111/150). Abstinence was significantly higher among initial responders than non-responders (PP 54 % vs. 32 %, p = .023 and CA 49 % vs. 21 %, p = .003). The odds ratios for initial responders vs. initial non-responders were, for PP = 2.5 (95 % CI 1.1–5.6, p = .024), and for CA = 3.7 (95 % CI 1.5–8.9, p = .004), after adjusting for proactive/reactive service.

Conclusions

Non-responders to a 12-month follow-up smoking cessation questionnaire in a quitline setting were more likely to be smokers 1.5–3 years later. We propose a conservative correction factor of 0.8 for self-reported abstinence in telephone-based cessation studies if the response rate is approximately 55–65 %.
Literature
1.
go back to reference World Health Organization. WHO report on the global tobacco epidemic. Geneva: World Health Organization; 2011. World Health Organization. WHO report on the global tobacco epidemic. Geneva: World Health Organization; 2011.
3.
go back to reference The National Board of Health and Welfare. Register data of the harmful effects of tobacco smoking. Stockholm: Socialstyrelsen [The National Board of Health and Welfare]; 2014. The National Board of Health and Welfare. Register data of the harmful effects of tobacco smoking. Stockholm: Socialstyrelsen [The National Board of Health and Welfare]; 2014.
4.
go back to reference Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville: U.S. Department of Health and Human Service. Public Health Service; 2008. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville: U.S. Department of Health and Human Service. Public Health Service; 2008.
5.
go back to reference Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013;8:CD002850.PubMed Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2013;8:CD002850.PubMed
6.
go back to reference Sogaard AJ, Selmer R, Bjertness E, Thelle D. The Oslo Health Study: The impact of self-selection in a large, population-based survey. Int J Equity Health. 2004;3(1):3.PubMedCentralCrossRefPubMed Sogaard AJ, Selmer R, Bjertness E, Thelle D. The Oslo Health Study: The impact of self-selection in a large, population-based survey. Int J Equity Health. 2004;3(1):3.PubMedCentralCrossRefPubMed
7.
go back to reference NAQC. Measuring quit rates. Quality Improvement Initiative. Phoenix: North American Quitline Consortium (NAQC); 2009. [January 19, 2016]. Available from: https://c.ymcdn.com/sites/naquitline.site-ym.com/resource/resmgr/docs/naqc_issuepaper_measuringqui.pdf. NAQC. Measuring quit rates. Quality Improvement Initiative. Phoenix: North American Quitline Consortium (NAQC); 2009. [January 19, 2016]. Available from: https://​c.​ymcdn.​com/​sites/​naquitline.​site-ym.​com/​resource/​resmgr/​docs/​naqc_​issuepaper_​measuringqui.​pdf.​
9.
go back to reference Tillgren P, Haglund BJ, Lundberg M, Romelsjo A. The sociodemographic pattern of tobacco cessation in the 1980s: results from a panel study of living condition surveys in Sweden. J Epidemiol Community Health. 1996;50(6):625–30.PubMedCentralCrossRefPubMed Tillgren P, Haglund BJ, Lundberg M, Romelsjo A. The sociodemographic pattern of tobacco cessation in the 1980s: results from a panel study of living condition surveys in Sweden. J Epidemiol Community Health. 1996;50(6):625–30.PubMedCentralCrossRefPubMed
10.
11.
go back to reference Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H. Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004;14(3):306–10.CrossRefPubMed Helgason AR, Tomson T, Lund KE, Galanti R, Ahnve S, Gilljam H. Factors related to abstinence in a telephone helpline for smoking cessation. Eur J Public Health. 2004;14(3):306–10.CrossRefPubMed
12.
go back to reference Tomson T, Helgason AR, Gilljam H. Quitline in smoking cessation: a cost-effectiveness analysis. Int J Technol Assess Health Care. 2004;20(4):469–74.CrossRefPubMed Tomson T, Helgason AR, Gilljam H. Quitline in smoking cessation: a cost-effectiveness analysis. Int J Technol Assess Health Care. 2004;20(4):469–74.CrossRefPubMed
13.
go back to reference Nohlert E, Ohrvik J, Helgason AR. Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial. Tob Induc Dis. 2014;12(1):9.PubMedCentralCrossRefPubMed Nohlert E, Ohrvik J, Helgason AR. Effectiveness of proactive and reactive services at the Swedish National Tobacco Quitline in a randomized trial. Tob Induc Dis. 2014;12(1):9.PubMedCentralCrossRefPubMed
14.
go back to reference Lindqvist H, Forsberg LG, Forsberg L, Rosendahl I, Enebrink P, Helgason AR. Motivational interviewing in an ordinary clinical setting: A controlled clinical trial at the Swedish National Tobacco Quitline. Addict Behav. 2013;38(7):2321–4.CrossRefPubMed Lindqvist H, Forsberg LG, Forsberg L, Rosendahl I, Enebrink P, Helgason AR. Motivational interviewing in an ordinary clinical setting: A controlled clinical trial at the Swedish National Tobacco Quitline. Addict Behav. 2013;38(7):2321–4.CrossRefPubMed
15.
go back to reference Nohlert E, Ohrvik J, Tegelberg A, Tillgren P, Helgason AR. Long-term follow-up of a high - and a low-intensity smoking cessation intervention in a dental setting--a randomized trial. BMC Public Health. 2013;13:592.PubMedCentralCrossRefPubMed Nohlert E, Ohrvik J, Tegelberg A, Tillgren P, Helgason AR. Long-term follow-up of a high - and a low-intensity smoking cessation intervention in a dental setting--a randomized trial. BMC Public Health. 2013;13:592.PubMedCentralCrossRefPubMed
16.
go back to reference Murray RP, Connett JE, Rand CS, Pan W, Anthonisen NR. Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years. Prev Med. 2002;35(4):314–9.CrossRefPubMed Murray RP, Connett JE, Rand CS, Pan W, Anthonisen NR. Persistence of the effect of the Lung Health Study (LHS) smoking intervention over eleven years. Prev Med. 2002;35(4):314–9.CrossRefPubMed
17.
go back to reference Miguez MC, Becona E. Abstinence from smoking ten years after participation in a randomized controlled trial of a self-help program. Addict Behav. 2008;33(10):1369–74.CrossRefPubMed Miguez MC, Becona E. Abstinence from smoking ten years after participation in a randomized controlled trial of a self-help program. Addict Behav. 2008;33(10):1369–74.CrossRefPubMed
18.
go back to reference Willemsen MC, van der Meer RM, Bor S. Description, effectiveness, and client satisfaction of 9 European Quitlines: Results of the European Smoking Cessation Helplines Evaluation Project (ESCHER). The Hague: STIVORO; 2008. Willemsen MC, van der Meer RM, Bor S. Description, effectiveness, and client satisfaction of 9 European Quitlines: Results of the European Smoking Cessation Helplines Evaluation Project (ESCHER). The Hague: STIVORO; 2008.
19.
go back to reference Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, et al. Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. BMJ. 2012;344:e1696.PubMedCentralCrossRefPubMed Ferguson J, Docherty G, Bauld L, Lewis S, Lorgelly P, Boyd KA, et al. Effect of offering different levels of support and free nicotine replacement therapy via an English national telephone quitline: randomised controlled trial. BMJ. 2012;344:e1696.PubMedCentralCrossRefPubMed
20.
go back to reference Lien RK, Schillo BA, Goto CJ, Porter L. The effect of survey nonresponse on quitline abstinence rates: Implications for practice. Nicotine Tob Res. 2016;18(1):98–101.PubMed Lien RK, Schillo BA, Goto CJ, Porter L. The effect of survey nonresponse on quitline abstinence rates: Implications for practice. Nicotine Tob Res. 2016;18(1):98–101.PubMed
21.
go back to reference Brogger J, Bakke P, Eide GE, Gulsvik A. Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. Am J Epidemiol. 2003;157(6):558–66.CrossRefPubMed Brogger J, Bakke P, Eide GE, Gulsvik A. Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey. Am J Epidemiol. 2003;157(6):558–66.CrossRefPubMed
22.
go back to reference Christensen AI, Ekholm O, Kristensen PL, Larsen FB, Vinding AL, Glumer C, et al. The effect of multiple reminders on response patterns in a Danish health survey. Eur J Public Health. 2015;25(1):156–61.CrossRefPubMed Christensen AI, Ekholm O, Kristensen PL, Larsen FB, Vinding AL, Glumer C, et al. The effect of multiple reminders on response patterns in a Danish health survey. Eur J Public Health. 2015;25(1):156–61.CrossRefPubMed
23.
go back to reference Verlato G, Melotti R, Olivieri M, Corsico A, Bugiani M, Accordini S, et al. Asthmatics and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. Respir Med. 2010;104(2):172–9.CrossRefPubMed Verlato G, Melotti R, Olivieri M, Corsico A, Bugiani M, Accordini S, et al. Asthmatics and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. Respir Med. 2010;104(2):172–9.CrossRefPubMed
24.
go back to reference Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Increasing response rates to postal questionnaires: systematic review. BMJ. 2002;324(7347):1183.PubMedCentralCrossRefPubMed Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, et al. Increasing response rates to postal questionnaires: systematic review. BMJ. 2002;324(7347):1183.PubMedCentralCrossRefPubMed
25.
go back to reference Nakash RA, Hutton JL, Jorstad-Stein EC, Gates S, Lamb SE. Maximising response to postal questionnaires - a systematic review of randomised trials in health research. BMC Med Res Methodol. 2006;6:5.PubMedCentralCrossRefPubMed Nakash RA, Hutton JL, Jorstad-Stein EC, Gates S, Lamb SE. Maximising response to postal questionnaires - a systematic review of randomised trials in health research. BMC Med Res Methodol. 2006;6:5.PubMedCentralCrossRefPubMed
26.
go back to reference Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;3:MR000008.PubMed Edwards PJ, Roberts I, Clarke MJ, Diguiseppi C, Wentz R, Kwan I, et al. Methods to increase response to postal and electronic questionnaires. Cochrane Database Syst Rev. 2009;3:MR000008.PubMed
27.
go back to reference Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149–59.CrossRef Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149–59.CrossRef
Metadata
Title
Non-responders in a quitline evaluation are more likely to be smokers – a drop-out and long-term follow-up study of the Swedish National Tobacco Quitline
Authors
Eva Nohlert
John Öhrvik
Ásgeir R. Helgason
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Tobacco Induced Diseases / Issue 1/2016
Electronic ISSN: 1617-9625
DOI
https://doi.org/10.1186/s12971-016-0070-2

Other articles of this Issue 1/2016

Tobacco Induced Diseases 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.